Literature DB >> 28338813

Antibiotic prescribing for acute respiratory infections in children in Jordan.

Mera A Ababneh1, Sayer I Al-Azzam1, Rawan Ababneh2, Abeer M Rababa'h1, Saddam Al Demour3.   

Abstract

Background: Most acute respiratory infections (ARIs) in children are due to viral etiology; however, over-prescribing of antibiotics for ARIs is common. The aim of this investigation was to identify antibiotic prescribing prevalence for children with ARIs and to identify predictors of broad-spectrum antibiotic prescribing.
Methods: This was a prospective cross sectional study in a sample of ambulatory care settings in Jordan. Children (<18 years) presenting with ARIs were assessed in terms of patient's demographics, antibiotic prescription and clinical diagnosis. Multivariable logistic regression analysis was used to identify predictors of broad-spectrum antibiotic prescription.
Results: Antibiotics were prescribed for 78.4% (4575/5829) of children with ARIs. Antibiotic prescription for ARIs for which antibiotics are not indicated was 69.2% (2688/3883). Broad-spectrum antibiotic prescription occurred in 51.1% (2337/4575) of all antibiotic-prescribed participants. Some of the predictors of broad-spectrum antibiotic prescription were: otitis media (OR 4.93 [95% CI 3.44-7.14]), tonsillitis (OR 6.03 [95% CI 4.39-8.33]), age 0-5 years (OR 1.17 [95% CI 1.02-1.38]) compared to age 6-12 years, fever (OR 2.14 [95% CI 1.78-2.59]), outpatient setting (OR 73 [95% CI 2.17-3.42]) and military sector (OR 2.29 [95% CI 1.82-2.90]). Conclusions: Antibiotic prescribing is high and often inappropriate. Predictors of broad-spectrum antibiotic prescribing were identified. Health policy initiatives should involve all stakeholders to minimize inappropriate antibiotic prescription and to prevent poor outcomes associated with such practice.
© The Author 2017. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acute respiratory infections; Antibiotics; Broad-spectrum antibiotics; Children; Jordan; Over-prescription

Mesh:

Substances:

Year:  2017        PMID: 28338813     DOI: 10.1093/inthealth/ihx003

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  5 in total

1.  Panel 6: Otitis media and associated hearing loss among disadvantaged populations and low to middle-income countries.

Authors:  Amanda Jane Leach; Preben Homøe; Clemence Chidziva; Hasantha Gunasekera; Kelvin Kong; Mahmood F Bhutta; Ramon Jensen; Sharon Ovnat Tamir; Sumon Kumar Das; Peter Morris
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2020-01-21       Impact factor: 1.675

2.  Factors associated with antibiotic prescribing in patients with acute respiratory tract complaints in Malta: a 1-year repeated cross-sectional surveillance study.

Authors:  Erika A Saliba-Gustafsson; Alexandra Dunberger Hampton; Peter Zarb; Nicola Orsini; Michael A Borg; Cecilia Stålsby Lundborg
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

Review 3.  Antibiotic prescribing in inpatient and outpatient settings in Iran: a systematic review and meta-analysis study.

Authors:  Ehsan Nabovati; Zhila TaherZadeh; Saeid Eslami; Ameen Abu-Hanna; Reza Abbasi
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-14       Impact factor: 4.887

4.  Antibiotic use for respiratory syncytial virus in the Middle East: A surveillance study in hospitalized Jordanian children.

Authors:  Danielle A Rankin; Nikhil K Khankari; Zaid Haddadin; Olla Hamdan; Ahmad Yanis; Samir Faouri; Asem Shehabi; John V Williams; Najwa Khuri-Bulos; Natasha B Halasa
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.752

5.  Prevalence and predictors of non-adherence to short-term antibiotics: A population-based survey.

Authors:  Basima A Almomani; Bushra M Hijazi; Oriana Awwad; Rawand A Khasawneh
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.